EAACI/GA2LEN/EDF guideline: management of urticaria
Top Cited Papers
- 23 January 2006
- Vol. 61 (3) , 321-331
- https://doi.org/10.1111/j.1398-9995.2005.00962.x
Abstract
This guideline is the result of a consensus reached during a panel discussion at the second International Consensus Meeting on Urticara, Urticaria 2004, a joint initiative of the EAACI Dermatology Section and GA2LEN. Urticaria has a profound impact on the quality of life, and effective treatment is therefore required. The recommended first line treatment are nonsedating H1 antihistamines. They have proven to be effective in double‐blind controlled studies, but dosages increased up to fourfold over the recommended doses may be necessary. However, for different urticaria subtypes and in view of individual variation in the course of the disease and response to treatment, additional or alternative therapies may be required. Immunosuppressive drugs like cyclosporin A and corticosteroids are not recommended for long‐term treatment due to unavoidable severe adverse effects. This guideline was, in addition, accepted by the European Dermatology Forum (EDF) and formally approved by the European Union of Medical Specialists (UEMS).Keywords
This publication has 106 references indexed in Scilit:
- Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticariaAnnals of Allergy, Asthma & Immunology, 2000
- Double-Blind Multicentre Comparative Study of Ebastine, Terfenadine and Placebo in the Treatment of Chronic Idiopathic Urticaria in AdultsDrugs, 1996
- Outpatient Management of Acute Urticaria: The Role of PrednisoneAnnals of Emergency Medicine, 1995
- Cetirizine and astemizole therapy for chronic idiopathic urticaria: A double-blind, placebo-controlled, comparative trialJournal of the American Academy of Dermatology, 1995
- Oral cyclosporine for severe chronic idiopathic urticaria and angioedemaJournal of the American Academy of Dermatology, 1991
- Therapeutic effects of cetirizine in delayed pressure urticaria: Clinicopathologic findingsJournal of the American Academy of Dermatology, 1991
- Comparison of cimetidine and diphenhydramine in the treatment of acute urticariaAnnals of Emergency Medicine, 1990
- Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticariaJournal of the American Academy of Dermatology, 1988
- Delayed pressure urticariaPublished by Elsevier ,1988
- Double-blind crossover study comparing doxepin with diphenhydramine for the treatment chronic urticariaJournal of the American Academy of Dermatology, 1985